{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:16:25Z","timestamp":1783034185040,"version":"3.54.6"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.ijtb.2024.05.001","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T07:22:37Z","timestamp":1715152957000},"page":"S214-S220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S2","title":["Comparison of treatment adherence among TB patients with and without COVID-19 in South India"],"prefix":"10.1016","volume":"71","author":[{"given":"Rajavardhana","family":"Thamineni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupalam","family":"Pradeepkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandana","family":"Padmapriya J","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8547-4541","authenticated-orcid":false,"given":"Mg","family":"Rajanandh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijtb.2024.05.001_bib1","series-title":"Global Tuberculosis Report 2020","year":"2020"},{"issue":"1","key":"10.1016\/j.ijtb.2024.05.001_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12941-020-00363-1","article-title":"Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes","volume":"19","author":"Togun","year":"2020","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"10.1016\/j.ijtb.2024.05.001_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01398-2020","article-title":"Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases","volume":"56","author":"Tadolini","year":"2020","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ijtb.2024.05.001_bib4","first-page":"486","article-title":"Vaccine effectiveness against severe laboratory-confirmed influenza in HIV-infected and\/or pregnant women during the 2018\u20132019 season in South Africa","volume":"14","author":"Nunes","year":"2020","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.ijtb.2024.05.001_bib5","first-page":"1230","article-title":"Patient adherence to tuberculosis treatment: a systematic review of","volume":"4","author":"Munro","year":"2007","journal-title":"Qual Res"},{"issue":"9","key":"10.1016\/j.ijtb.2024.05.001_bib6","first-page":"997","article-title":"\"Sputnik\": a programmatic approach to improve tuberculosis treatment adherence and outcome among defaulters","volume":"21","author":"Gelmanova","year":"2017","journal-title":"Int J Tubercul Lung Dis"},{"issue":"11","key":"10.1016\/j.ijtb.2024.05.001_bib7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/tmi.13824","article-title":"Level of adherence to anti\u2010tubercular treatment among drug\u2010sensitive tuberculosis patients on a newly introduced daily dose regimen in South India: a cross\u2010sectional study","volume":"27","author":"Thamineni","year":"2022","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ijtb.2024.05.001_bib8","doi-asserted-by":"crossref","DOI":"10.18231\/j.ijfcm.2021.001","article-title":"Modified Kuppuswamy socioeconomic scale updated for the year 2021","volume":"8","author":"Saleem","year":"2021","journal-title":"Indian J Forensic Community Med"},{"key":"10.1016\/j.ijtb.2024.05.001_bib9","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4103\/jfmpc.jfmpc_51_19","article-title":"Knowledge about tuberculosis among pulmonary tuberculosis patients: a cross-sectional study from Uttarakhand","volume":"8","author":"Nautiyal","year":"2019","journal-title":"J Fam Med Prim Care"},{"key":"10.1016\/j.ijtb.2024.05.001_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.14193","article-title":"The Medication Adherence Report Scale: a measurement tool for eliciting patients' reports of nonadherence","volume":"86","author":"Chan","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijtb.2024.05.001_bib11","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0731-7085(98)00112-5","article-title":"Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method","volume":"18","author":"Panchagnula","year":"1999","journal-title":"J Pharmaceut Biomed Anal"},{"key":"10.1016\/j.ijtb.2024.05.001_bib12","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.5740\/jaoacint.14-237","article-title":"Development and validation of an HPLC method for simultaneous determination of rifampicin, isoniazid, pyrazinamide, and ethambutol hydrochloride in pharmaceutical formulations","volume":"98","author":"Chellini","year":"2015","journal-title":"J AOAC Int"},{"issue":"3","key":"10.1016\/j.ijtb.2024.05.001_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11523-020-00721-1","article-title":"Impact of the COVID-19 outbreak on the management of patients with cancer","volume":"15","author":"Raymond","year":"2020","journal-title":"Targeted Oncol"},{"issue":"10","key":"10.1016\/j.ijtb.2024.05.001_bib14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/trstmh\/traa072","article-title":"Neglecting the effect of COVID-19 on neglected tropical diseases: the Ethiopian perspective","volume":"114","author":"Abdela","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.ijtb.2024.05.001_bib15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1186\/s12879-022-07787-4","article-title":"Tuberculosis treatment adherence in the era of COVID-19","volume":"22","author":"Lippincott","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijtb.2024.05.001_bib16","series-title":"IJPM Determinants of Poor Adherence to Anti-tuberculosis Treatment in Mumbai, India","author":"Bagchi","year":"2010"},{"key":"10.1016\/j.ijtb.2024.05.001_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-017-4188-9","article-title":"The prevalence and factors associated for anti-tuberculosis treatment non-adherence among pulmonary tuberculosis patients in public health care facilities in South Ethiopia: a cross-sectional study","volume":"17","author":"Woimo","year":"2017","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.ijtb.2024.05.001_bib18","article-title":"Measuring tuberculosis medication adherence: a comparison of multiple approaches in relation to urine isoniazid metabolite testing within a cohort study in India","author":"Subbaraman","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijtb.2024.05.001_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-018-3789-4","article-title":"Non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers, Northwest Ethiopia","volume":"11","author":"Mekonnen","year":"2018","journal-title":"BMC Res Notes"},{"issue":"10","key":"10.1016\/j.ijtb.2024.05.001_bib20","doi-asserted-by":"crossref","first-page":"778","DOI":"10.5588\/ijtld.23.0054","article-title":"Adherence to treatment on a daily-dose regimen for TB","volume":"27","author":"Rajavardhana","year":"2023","journal-title":"Int J Tubercul Lung Dis"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570724000763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570724000763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:56:34Z","timestamp":1747209394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570724000763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":20,"alternative-id":["S0019570724000763"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2024.05.001","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of treatment adherence among TB patients with and without COVID-19 in South India","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2024.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of Tuberculosis Association of India.","name":"copyright","label":"Copyright"}]}}